QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
about
Angel of human health: current research updates in toad medicineExtracellular Antibody Drug Conjugates Exploiting the Proximity of Two ProteinsThe cephalostatins. 22. synthesis of bis-steroidal pyrazine pyrones (1)Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides.Bufadienolides and their antitumor activity.Modulators of Na/K-ATPase: a patent review.Anticancer steroids: linking natural and semi-synthetic compounds.Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.Urinary metabolites of cinobufagin in rats and their antiproliferative activities.Specific 12 beta-hydroxylation of cinobufagin by filamentous fungi.Identification of cinobufagin metabolites in the bile of rats.Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides.Interspecies variation in phase I metabolism of bufalin in hepatic microsomes from mouse, rat, dog, minipig, monkey, and human.
P2860
Q27009993-DE1256C4-F124-4D0B-A2DB-032E2D5635F4Q36081864-0C43C765-B2BF-4959-8F1C-0590071C854FQ36133182-BBC5E917-CFB0-4BB9-8CDE-DD28774F8094Q36544066-6CD33325-3AD5-4542-9BFA-0E420205EF2EQ36819636-54CC8BF3-8EDD-40FB-A49B-3E36D579EC18Q37854486-7D9C12E4-4A55-47CD-85BC-86C220A566AFQ38010820-77A00130-7760-4EE6-AA50-9DE06363F816Q38059807-14AD9CB7-58F2-4D09-B6CB-1F03D616B736Q39197590-0A16454B-0319-4C2E-ADB4-35E6AD51D073Q39462805-B06A8553-8B0B-4EE4-B66B-81D610BBE87BQ39516598-F03E10FF-0535-4C64-900A-F78CFC31E172Q40548080-29FA47C3-712C-417E-96BA-6A46CBDFC0D8Q43247038-54C36B25-D213-4A04-B027-24F1CE045BE0Q43263297-4001CAAB-013A-4521-A2ED-B7C498D168A4Q46051646-D7416165-546A-4F9F-94CC-AA88AC72DAFFQ46718054-4E9B8623-5EA4-412D-9074-9AB0843DE66B
P2860
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
QSAR evaluation of the Ch'an S ...... cinoma cell line PLC/PRF/5(1).
@en
type
label
QSAR evaluation of the Ch'an S ...... cinoma cell line PLC/PRF/5(1).
@en
prefLabel
QSAR evaluation of the Ch'an S ...... cinoma cell line PLC/PRF/5(1).
@en
P2093
P356
P1476
QSAR evaluation of the Ch'an S ...... cinoma cell line PLC/PRF/5(1).
@en
P2093
Ayako Yukita
Ayano Yamashita
George R Pettit
Hideji Itokawa
Hiroshi Morita
Koichi Takeya
Kyoko Saito
Mariko Katsuyama
Toshiaki Segawa
Toshihiko Nogawa
P304
P356
10.1021/JM0202066
P407
P577
2002-12-01T00:00:00Z